Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT
Prospective survey evaluating CMV and other herpesvirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections [Phase 1]
Phase 1 clinical trial evaluating R-MVST cells for the treatment of viral infections, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection [Phase 2]
Phase 2 trial evaluating prevention of cytomegalovirus infection in kidney transplant recipients using T gamma delta-CD16+ cells in combinat…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: ATG Individualized Dosing Model in URD-PBSCT. [Phase 2]
Phase 2 trial updating an individualized dosing model of antithymocyte globulin in unrelated donor peripheral blood stem cell transplantatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
This clinical trial update reports the completion of a study evaluating the Viracor CMV assay to guide valganciclovir prophylaxis in high-ri…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: HCMV Breakthrough Infections During Letermovir Prophylaxis [NA]
Clinical trial update reporting breakthrough cytomegalovirus infections occurring despite letermovir prophylaxis in hematopoietic stem cell …
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Non Primary HCMV Infection: Natural History and Immune Response
This clinical trial update concerns non-primary cytomegalovirus infection, focusing on its natural history and immune response. The study is…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells [Phase 1]
The update describes a Phase 1 trial evaluating viral-specific T cell therapy for cytomegalovirus infections, which has been terminated.
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Expansion of Virus-Specific Lymphocytes for Cell Therapy [Phase 1]
Phase 1 study expanding virus-specific lymphocytes for cytomegalovirus infection and CMV viremia is currently recruiting. Sponsor: Hospital …
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating third-party donor-derived CMVpp65-specific T cells for cytomegalovirus infection or persistent CMV viremia after al…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients [Phase 1]
Phase 1 study evaluating the safety, tolerability, and immunogenicity of the CMV vaccine ASP0113 in CMV-seropositive and CMV-seronegative he…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Study of CMV in Kidney Transplant Recipients
A terminated clinical trial studied cytomegalovirus viral loads in seropositive kidney transplant recipients.
-
FDA approval · 2024-08-30FDA Approved: PREVYMIS — Original Application (Merck Sharp & Dohme LLC)
FDA approved PREVYMIS (letermovir) from Merck for prophylaxis of cytomegalovirus infection in CMV-seropositive adults receiving an allogenei…
-
FDA approval · 2024-08-30FDA Approved: PREVYMIS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA granted approval of a supplemental application for PREVYMIS (Letermovir) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection wi…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy [Phase 2]
A Phase 2 clinical trial evaluating adoptive cell immunotherapy as prophylaxis against cytomegalovirus infection is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Evaluation of CMV/EBV-CMI in Haploid HSCT
A study evaluating CMV/EBV-specific cellular immune responses in haploid hematopoietic stem cell transplantation is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
This clinical trial update reports a study on cytomegalovirus reactivation in ICU patients requiring prolonged mechanical ventilation, and t…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.
Multicenter qualitative and quantitative study in France aims to identify determinants of participation in a cytomegalovirus preventive vacc…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
A cohort-study analysis evaluating the incidence and risk factors of CMV reactivation in patients receiving CAR-T cell therapy for relapse o…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection [Phase 3]
Phase 3 trial in Japanese patients with cytomegalovirus infection has completed and posted results for maribavir.
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection [Phase 2]
A Phase 2a study of IV BCV for adenovirus infection is currently recruiting, with cytomegalovirus infection also listed among the conditions…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cytomegalovirus Shedding Characteristics in Pregnant Women
The document notes that a clinical trial studying cytomegalovirus shedding in pregnant women has completed and posted results.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT
A clinical trial evaluating whether Letermovir prophylaxis enhances CMV-specific immune reconstitution after umbilical cord blood transplant…